21
Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP
Condition(s):Gastric Cancer; Histone Deacetylase InhibitorLast Updated:January 7, 2020Completed
Histone Deacetylase Inhibitors: 749 Clinical Trials, Page 3 of 75
Hide Studies Not Open or Pending
22
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL
Condition(s):Leukemia, Acute; Leukemia, T Cell; Leukemia, LymphoblasticLast Updated:June 12, 2018Unknown status
23
HDAC Inhibitor Augmentation to Clozapine
Condition(s):SchizophreniaLast Updated:February 22, 2019Withdrawn
24
Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies
Condition(s):Hematological Disease; Lymphoid MalignanciesLast Updated:November 28, 2011Completed
25
Phase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic Leukemia
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:January 27, 2022Terminated
26
Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases
Condition(s):Myeloproliferative DiseasesLast Updated:December 3, 2019Completed
27
Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia
Condition(s):LeukemiaLast Updated:August 15, 2014Completed
28
A Pilot Study of Pivanex in Patients With Malignant Melanoma
Condition(s):Malignant MelanomaLast Updated:August 30, 2005Terminated
29
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
Condition(s):Leukemia; Leukemia, Acute; Adult Lymphoblastic Lymphoma; Leukemia, Lymphoblastic; Leukemia, T Cell; Adult Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoblastic LeukemiaLast Updated:June 21, 2018Unknown status
30
Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy
Condition(s):HIV InfectionLast Updated:March 15, 2023Active, not recruiting